Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial. Issue 5 (6th February 2023)

Record Type:
Journal Article
Title:
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial. Issue 5 (6th February 2023)
Main Title:
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial
Authors:
Koshino, Akihiko
Oshima, Megumi
Arnott, Clare
Fletcher, Robert A.
Bakris, George L.
Jardine, Meg
Mahaffey, Kenneth W.
Perkovic, Vlado
Pollock, Carol
Heerspink, Hiddo J. L.
Neuen, Brendon L.
Abstract:
Is Part Of:
Diabetes, obesity & metabolism. Volume 25:Issue 5(2023)
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 5(2023)
Issue Display:
Volume 25, Issue 5 (2023)
Year:
2023
Volume:
25
Issue:
5
Issue Sort Value:
2023-0025-0005-0000
Page Start:
1413
Page End:
1418
Publication Date:
2023-02-06
Subjects:
cardiovascular disease -- clinical trial -- diabetic nephropathy -- fatty liver disease
Diabetes -- Periodicals
Obesity -- Periodicals
Metabolism -- Disorders -- Periodicals
Clinical pharmacology -- Periodicals
616.462
Journal URLs:
http://www.blackwellpublishing.com/journal.asp?ref=1462-8902&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1111/dom.14978 ↗
Languages:
English
ISSNs:
1462-8902
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3579.601970
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
26904.xml